Table 4.
Metabolites identified in obese BC compared with non-obese BC patients.
Category | Compound | Log2FC | p-value |
---|---|---|---|
Metabolite involved in epigenetic | Ornithine | 2.42 | <0.0001 |
7-Methyladenine | 2.40 | <0.0001 | |
2-Oxoarginine | 1.74 | <0.0001 | |
Metabolite involved in citric acid cycle | L-Carnitine | 1.83 | <0.0001 |
Glycerol 3-phosphate | 2.38 | <0.0001 | |
L-2-Hydroxyglutaric acid | 0.71 | 0.0004 | |
Pentanoyl-CoA | −1.95 | 0.0001 | |
Amino acid metabolism | Ornithine | 2.42 | <0.0001 |
2-Oxoarginine | 1.74 | <0.0001 | |
Serotonin | 0.73 | 0.0003 | |
Histamine | 0.76 | 0.003 | |
Tryptophan | 0.42 | 0.024 | |
L-Homoserine | 0.44 | 0.038 | |
D-Leucine | 2.34 | <0.0001 | |
3-Hydroxyphenylacetic acid | −4.97 | <0.0001 | |
Carbamoyl phosphate | −1.36 | 0.0001 | |
FAD | −2.28 | 0.0002 | |
Epinephrine | −0.33 | 0.0003 | |
Creatinine | −0.40 | 0.01 | |
Cholesterol and fatty acid metabolites | 25-Hydroxycholesterol | 2.31 | <0.0001 |
Cholestenone | −7.85 | <0.0001 | |
TG[16:0/14:1(9Z)/18:4(6Z,9Z,12Z,15Z)] | −1.52 | 0.0006 | |
Alpha-Linolenic acid | −0.77 | 0.002 | |
Hexanoyl-CoA | −1.71 | 0.0004 | |
Neurotransmitters | Epinephrine | −0.33 | 0.0003 |
Serotonin | 0.73 | 0.0003 | |
SM[d19:1/24:1(15Z)] | 6.55 | 0.0008 | |
Histamine | 0.76 | 0.003 | |
Acetylcholine | 0.55 | 0.007 |
FC, fold change.